These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 30781380)

  • 1. In Vitro Activity of 3-Bromopyruvate, an Anticancer Compound, Against Antibiotic-Susceptible and Antibiotic-Resistant
    Krzyżek P; Franiczek R; Krzyżanowska B; Łaczmański Ł; Migdał P; Gościniak G
    Cancers (Basel); 2019 Feb; 11(2):. PubMed ID: 30781380
    [No Abstract]   [Full Text] [Related]  

  • 2. In Vitro Activity of Sertraline, an Antidepressant, Against Antibiotic-Susceptible and Antibiotic-Resistant
    Krzyżek P; Franiczek R; Krzyżanowska B; Łaczmański Ł; Migdał P; Gościniak G
    Pathogens; 2019 Nov; 8(4):. PubMed ID: 31717683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphological and Bactericidal Effects of Different Antibiotics on Helicobacter pylori.
    Faghri J; Poursina F; Moghim S; Zarkesh Esfahani H; Nasr Esfahani B; Fazeli H; Mirzaei N; Jamshidian A; Ghasemian Safaei H
    Jundishapur J Microbiol; 2014 Jan; 7(1):e8704. PubMed ID: 25147656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial and Antibiofilm Activities of New Synthesized Silver Ultra-NanoClusters (SUNCs) Against
    Grande R; Sisto F; Puca V; Carradori S; Ronci M; Aceto A; Muraro R; Mincione G; Scotti L
    Front Microbiol; 2020; 11():1705. PubMed ID: 32849359
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative in vitro antimicrobial susceptibility and synergistic activity of antimicrobial combinations against Helicobacter pylori isolates in Taiwan.
    Cheng A; Sheng WH; Liou JM; Wang HP; Wu MS; Lin JT; Chang SC
    J Microbiol Immunol Infect; 2015 Feb; 48(1):72-9. PubMed ID: 23036269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory and bactericidal activity of rokitamycin against Helicobacter pylori and morphological alterations.
    Brenciaglia MI; Fornara AM; Scaltrito MM; Braga PC
    J Chemother; 1996 Dec; 8(6):425-31. PubMed ID: 8981182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changing patterns of antibiotic resistance of Helicobacter pylori in patients with peptic ulcer disease].
    Bang SY; Han DS; Eun CS; Kim JE; Ahn SB; Sohn JH; Jeon YC; Kang JO
    Korean J Gastroenterol; 2007 Dec; 50(6):356-62. PubMed ID: 18159172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vitro Activity of the Arylaminoartemisinin GC012 against
    Sisto F; Carradori S; D'Alessandro S; Santo N; Lattuada N; Haynes RK; Taramelli D; Grande R
    Pathogens; 2022 Jun; 11(7):. PubMed ID: 35889986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rifabutin and Furazolidone Could Be the Candidates of the Rescue Regimen for Antibiotic-Resistant
    Choi YI; Jeong SH; Chung JW; Park DK; Kim KO; Kwon KA; Kim YJ; So S; Lee JH; Jeong JY; Lee SM
    Can J Infect Dis Med Microbiol; 2019; 2019():9351801. PubMed ID: 31360270
    [No Abstract]   [Full Text] [Related]  

  • 10. Antimicrobial Effect of a Proteolytic Enzyme From the Fruits of
    Salinas Ibáñez ÁG; Vallés D; Adaro M; Barberis S; Vega AE
    Front Nutr; 2021; 8():699955. PubMed ID: 34977105
    [No Abstract]   [Full Text] [Related]  

  • 11. Potential of Bacterial Cellulose Chemisorbed with Anti-Metabolites, 3-Bromopyruvate or Sertraline, to Fight against
    Krzyżek P; Gościniak G; Fijałkowski K; Migdał P; Dziadas M; Owczarek A; Czajkowska J; Aniołek O; Junka A
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33327555
    [No Abstract]   [Full Text] [Related]  

  • 12. ANTIBIOTIC RESISTANCE SURVEILLANCE OF HELICOBACTER PYLORI AT THE BIOBÍO REGION (CHILE) IN A DECADE.
    Parra-Sepúlveda C; Merino JS; Sáez-Carrillo K; González C; García-Cancino A
    Arq Gastroenterol; 2019; 56(4):361-366. PubMed ID: 31721972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Helicobacter pylori biofilm formation on susceptibility to amoxicillin, metronidazole and clarithromycin.
    Yonezawa H; Osaki T; Hojo F; Kamiya S
    Microb Pathog; 2019 Jul; 132():100-108. PubMed ID: 31034965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Broad spectrum resistance in Helicobacter pylori isolated from gastric biopsies of patients with dyspepsia in Cameroon and efflux-mediated multiresistance detection in MDR isolates.
    Kouitcheu Mabeku LB; Eyoum Bille B; Tepap Zemnou C; Tali Nguefack LD; Leundji H
    BMC Infect Dis; 2019 Oct; 19(1):880. PubMed ID: 31640588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial susceptibility testing of Helicobacter pylori. Comparison of E-test, broth microdilution, and disk diffusion for ampicillin, clarithromycin, and metronidazole.
    Hachem CY; Clarridge JE; Reddy R; Flamm R; Evans DG; Tanaka SK; Graham DY
    Diagn Microbiol Infect Dis; 1996 Jan; 24(1):37-41. PubMed ID: 8988762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic MICs and short time-killing against Helicobacter pylori: therapeutic potential of kanamycin.
    Irie Y; Tateda K; Matsumoto T; Miyazaki S; Yamaguchi K
    J Antimicrob Chemother; 1997 Aug; 40(2):235-40. PubMed ID: 9301989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiofilm and Antimicrobial-Enhancing Activity of
    Krzyżek P; Junka A; Słupski W; Dołowacka-Jóźwiak A; Płachno BJ; Sobiecka A; Matkowski A; Chodaczek G; Płusa T; Gościniak G; Zielińska S
    Pathogens; 2021 Aug; 10(8):. PubMed ID: 34451497
    [No Abstract]   [Full Text] [Related]  

  • 18. Synergistic Therapies as a Promising Option for the Treatment of Antibiotic-Resistant
    Krzyżek P; Paluch E; Gościniak G
    Antibiotics (Basel); 2020 Sep; 9(10):. PubMed ID: 33007899
    [No Abstract]   [Full Text] [Related]  

  • 19. Antibiotic susceptibility of Helicobacter pylori clinical isolates: comparative evaluation of disk-diffusion and E-test methods.
    Mishra KK; Srivastava S; Garg A; Ayyagari A
    Curr Microbiol; 2006 Oct; 53(4):329-34. PubMed ID: 16972131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of a novel antimicrobial agent, TG44, for treatment of Helicobacter pylori infection.
    Kamoda O; Anzai K; Mizoguchi J; Shiojiri M; Yanagi T; Nishino T; Kamiya S
    Antimicrob Agents Chemother; 2006 Sep; 50(9):3062-9. PubMed ID: 16940102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.